<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>The State of CV Health in the US; Semaglutide and Reduced Hospital Admissions; D-Dimer and Its Use in Ruling Out DVT</title>
  <description> In this week’s View, Dr. Eagle comments on&amp;amp;nbsp;the recently published&amp;amp;nbsp;JACC&amp;amp;nbsp;Cardiovascular&amp;amp;nbsp;(CV)&amp;amp;nbsp;Statistics report which&amp;amp;nbsp;evaluates the management of&amp;amp;nbsp;CV&amp;amp;nbsp;risk factors&amp;amp;nbsp;in the United States. He then explores the&amp;amp;nbsp;use of semaglutide and its association with reduced hospital admissions and length of stay. Finally, Dr. Eagle&amp;amp;nbsp;examines&amp;amp;nbsp;the multicenter,&amp;amp;nbsp;multinational ADJUST-DVT study on&amp;amp;nbsp;the&amp;amp;nbsp;age-adjusted&amp;amp;nbsp;use of&amp;amp;nbsp;D-dimer&amp;amp;nbsp;cut-offs&amp;amp;nbsp;for&amp;amp;nbsp;patients&amp;amp;nbsp;with suspected&amp;amp;nbsp;deep&amp;amp;nbsp;vein&amp;amp;nbsp;thrombosis.   &amp;amp;nbsp;    Subscribe to Eagle’s Eye View  &amp;amp;nbsp;  </description>
  <author_name>Eagle's Eye View: Your Weekly CV Update From ACC.org</author_name>
  <author_url>http://www.acc.org</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/39802370/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/197696170</thumbnail_url>
</oembed>
